Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Safety and effectiveness of Natrelle™ Cohesive Round Silicone-Filled Breast Implants in women undergoing primary reconstruction or revision of existing breast implants.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Experimental | Primary reconstruction |
|
| 2 | Experimental | Revision-reconstruction |
|
| 3 | Experimental | Revision-augmentation |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Natrelle(TM) Silicone-Filled Breast Implants | Device | Breast implant surgery |
|
| Measure | Description | Time Frame |
|---|---|---|
| Local Complications | By patient risk of complications occurring in at least 5% of patients in 1 or more cohorts | 5 years |
| Measure | Description | Time Frame |
|---|---|---|
| Satisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point Scale | Satisfaction score on a 5-point scale, where 1 is definitely dissatisfied and 5 is definitely satisfied | 5 years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Indianapolis | Indiana | United States |
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Reconstruction | Women who have undergone Breast Reconstruction |
| FG001 | Revision | Women who have undergone Revision of a Breast Augmentation or Reconstruction |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Reconstruction | Women who have undergone Breast Reconstruction |
| BG001 | Revision | Women who have undergone Revision of a Breast Augmentation or Reconstruction |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Customized | Number |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Local Complications | By patient risk of complications occurring in at least 5% of patients in 1 or more cohorts | All enrolled patients | Number | 95% Confidence Interval | Percentage by Patient | 5 years |
|
|
Not provided
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Reconstruction | Women who have undergone Breast Reconstruction |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Medical Monitor | Allergan, Inc. | 714-246-4500 | clinicaltrials@allergan.com |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| BG002 | Total | Total of all reporting groups |
| participants |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Participants |
|
|
| Secondary | Satisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point Scale | Satisfaction score on a 5-point scale, where 1 is definitely dissatisfied and 5 is definitely satisfied | All patients who had a breast implant satisfaction rating | Mean | Standard Deviation | Units on a scale | 5 years |
|
|
|
| 0 |
| 45,055 |
| 0 |
| 45,055 |
| EG001 | Revision | Women who have undergone Revision of a Breast Augmentation or Reconstruction | 0 | 39,274 | 0 | 39,274 |
A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.